Rafael G Amado from San Mateo, CA, age 60

Resumes

Executive Vice President, Head Of R And D And Chief Medical Officer

view source

Location:

3711 Market St, Philadelphia, PA 19104

Industry:

Biotechnology

Work:

Allogene Therapeutics
Executive Vice President, Head of R and D and Chief Medical Officer
Adaptimmune Us Aug 2018 - Jul 2019
President Research and Development
Adaptimmune Us Mar 2015 - Jul 2018
Chief Medical Officer
Gsk 2008 - Mar 2015
Senior Vice President, Head of Oncology R and D
Gsk Aug 2008 - Jan 2011
Vice President

Education:

University of California, Los Angeles 1992 - 2003
Doctor of Medicine, Doctorates University of California

Skills:

R&D
Medical Devices
Oncology
Biotechnology
Drug Development
Clinical Trials
Technology Transfer
Pharmaceutical Industry
Medicine
Ctms
Cross Functional Team Leadership
Life Sciences
Biopharmaceuticals
Cro
Lifesciences
Clinical Development
Drug Discovery
Gcp
Fda
Cancer
Regulatory Submissions
Commercialization
Clinical Research
Regulatory Affairs
Immunology

Rafael Amado

view source

Rafael Franco Amado

view source

Rafael Amado

view source

Location:

United States

News

FDA Grants T-Cell Therapy Breakthrough Designation in Sarcoma

view source

e are pleased that the FDA has granted breakthrough therapy designation for our T-cell therapy in synovial sarcoma, recognizing both the unmet need for patients suffering from this disease as well as the promise of these early data, said Rafael Amado, MD, chief medical officer at Adaptimmune. We l
Date: Feb 09, 2016
Category: Health
Source: Google

Adaptimmune wins 'breakthrough' tag

view source

"We are pleased that the FDA has granted breakthrough therapy designation for our T-cell therapy in synovial sarcoma, recognizing both the unmet need for patients suffering from this disease as well as the promise of these early data," said Rafael Amado, Adaptimmune's chief medical officer. "We look
Date: Feb 09, 2016
Category: Health
Source: Google

U.S. Food and Drug Administration Grants Breakthrough Therapy Designation for Adaptim...

view source

re pleased that the FDA has granted Breakthrough Therapy designation for our T-cell therapy in synovial sarcoma, recognizingboth the unmet need for patientssuffering from this disease as well asthe promise of these early data, saidDr. Rafael Amado, Adaptimmunes Chief Medical Officer.We look
Date: Feb 09, 2016
Category: Health
Source: Google

Scheduled Conference Calls, License Agreements, Dividends, Preliminary ...

view source

patients during the first four cycles of treatment. Dr. Rafael Amado, Senior Vice President Oncology R&D at GSK, said, "Cytopenias are important complications of MDS which tend to worsen with azacitidine treatment. Currently, there are no approved treatments for MDS that stimulate platelet production.
Date: Jun 30, 2014
Category: Business
Source: Google

GSK and Genmab announce top-line results from a Phase III study of ...

view source

scientific community as soon it became available. We will now work to further analyse the data and to better understand the totality of the efficacy and safety findings," said Dr. Rafael Amado, Head of Oncology R&D at GSK. "We are very grateful to the CLL patients who participated in this trial.
Date: Jun 27, 2014
Category: Health
Source: Google

Glaxo's Arzerra Lukemia Drug Misses Key Target in Clinical Trial

view source

It was our priority to share this result with the scientific community as soon as it became available, said Dr. Rafael Amado, head of oncology R&D at Glaxo. We will now work to further analyze the data and to better understand the totality of the efficacy and safety findings.
Date: Jun 27, 2014
Category: Health
Source: Google

Tykerb, Avastin suffer disappointing data at SABCS

view source

had a slightly improved rate of progression-free survival, the difference when compared with placebo wasn't statistically significant. "Although we are disappointed,"GSK SVP Rafael Amado said, "[Tykerb] remains an important treatment option for patients with metastasis HER2-positive breast cancer."
Date: Dec 09, 2011
Category: Health
Source: Google